Biotrend Cevre (Turkey) Probability of Future Stock Price Finishing Over 18.91
| BIOEN Stock | TRY 17.85 0.15 0.85% |
Biotrend |
Biotrend Cevre Target Price Odds to finish over 18.91
The tendency of Biotrend Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over 18.91 or more in 90 days |
| 17.85 | 90 days | 18.91 | about 7.39 |
Based on a normal probability distribution, the odds of Biotrend Cevre to move over 18.91 or more in 90 days from now is about 7.39 (This Biotrend Cevre ve probability density function shows the probability of Biotrend Stock to fall within a particular range of prices over 90 days) . Probability of Biotrend Cevre ve price to stay between its current price of 17.85 and 18.91 at the end of the 90-day period is about 25.68 .
Assuming the 90 days trading horizon Biotrend Cevre ve has a beta of -0.17 suggesting as returns on the benchmark increase, returns on holding Biotrend Cevre are expected to decrease at a much lower rate. During a bear market, however, Biotrend Cevre ve is likely to outperform the market. Additionally Biotrend Cevre ve has an alpha of 0.029, implying that it can generate a 0.029 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Biotrend Cevre Price Density |
| Price |
Predictive Modules for Biotrend Cevre
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Biotrend Cevre ve. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Biotrend Cevre Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Biotrend Cevre is not an exception. The market had few large corrections towards the Biotrend Cevre's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Biotrend Cevre ve, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Biotrend Cevre within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.03 | |
β | Beta against Dow Jones | -0.17 | |
σ | Overall volatility | 1.05 | |
Ir | Information ratio | 0 |
Biotrend Cevre Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Biotrend Cevre for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Biotrend Cevre ve can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Biotrend Cevre ve has accumulated 696.56 M in total debt with debt to equity ratio (D/E) of 2.09, implying the company greatly relies on financing operations through barrowing. Biotrend Cevre ve has a current ratio of 0.75, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Biotrend Cevre until it has trouble settling it off, either with new capital or with free cash flow. So, Biotrend Cevre's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Biotrend Cevre ve sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Biotrend to invest in growth at high rates of return. When we think about Biotrend Cevre's use of debt, we should always consider it together with cash and equity. | |
| Biotrend Cevre ve has accumulated about 25.91 M in cash with (326.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.2. | |
| Roughly 67.0% of Biotrend Cevre shares are held by company insiders |
Biotrend Cevre Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Biotrend Stock often depends not only on the future outlook of the current and potential Biotrend Cevre's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Biotrend Cevre's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 500 M |
Biotrend Cevre Technical Analysis
Biotrend Cevre's future price can be derived by breaking down and analyzing its technical indicators over time. Biotrend Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Biotrend Cevre ve. In general, you should focus on analyzing Biotrend Stock price patterns and their correlations with different microeconomic environments and drivers.
Biotrend Cevre Predictive Forecast Models
Biotrend Cevre's time-series forecasting models is one of many Biotrend Cevre's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Biotrend Cevre's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Biotrend Cevre ve
Checking the ongoing alerts about Biotrend Cevre for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Biotrend Cevre ve help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Biotrend Cevre ve has accumulated 696.56 M in total debt with debt to equity ratio (D/E) of 2.09, implying the company greatly relies on financing operations through barrowing. Biotrend Cevre ve has a current ratio of 0.75, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Biotrend Cevre until it has trouble settling it off, either with new capital or with free cash flow. So, Biotrend Cevre's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Biotrend Cevre ve sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Biotrend to invest in growth at high rates of return. When we think about Biotrend Cevre's use of debt, we should always consider it together with cash and equity. | |
| Biotrend Cevre ve has accumulated about 25.91 M in cash with (326.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.2. | |
| Roughly 67.0% of Biotrend Cevre shares are held by company insiders |
Other Information on Investing in Biotrend Stock
Biotrend Cevre financial ratios help investors to determine whether Biotrend Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotrend with respect to the benefits of owning Biotrend Cevre security.